UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

JAMA : the journal of the American Medical Association, 2011-11, Vol.306 (17), p.1874

2011

Link zum Volltext

Verfügbarkeit prüfen

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

PloS one, 2016-12, Vol.11 (12), p.e0168210-e0168210

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-12, Vol.8 (12)

2013

Link zum Volltext

Verfügbarkeit prüfen

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-09, Vol.8 (9)

2013

Link zum Volltext

Verfügbarkeit prüfen

Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2

PloS one, 2014-04, Vol.9 (4), p.e94892-e94892

2014

Link zum Volltext

Verfügbarkeit prüfen

Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors

PloS one, 2012-02, Vol.7 (2), p.e31420-e31420

2012

Link zum Volltext

Verfügbarkeit prüfen

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

American journal of hematology, 2008-07, Vol.83 (7), p.563-569

2008

Link zum Volltext

Verfügbarkeit prüfen

MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides

PloS one, 2013, Vol.8 (9), p.e73648-e73648

2013

Link zum Volltext

Verfügbarkeit prüfen

Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.(Research Article)

PloS one, 2016-12, Vol.11 (12), p.e0168210

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Haematologica (Roma), 2014-10, Vol.99 (10), p.1624-1631

2014

Link zum Volltext

Verfügbarkeit prüfen

Haematopoietic stem cell transplantation with non‐myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution

British journal of haematology, 2004-04, Vol.125 (2), p.225-231

2004

Link zum Volltext

Verfügbarkeit prüfen

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

Critical care (London, England), 2008-01, Vol.12 (3), p.R83-R83

2008

Link zum Volltext

Verfügbarkeit prüfen

MHC Class II Tetramers Made from Isolated Recombinant [alpha] and [beta] Chains Refolded with Affinity-Tagged Peptides.(Research Article)

PloS one, 2013-09, Vol.8 (9), p.e73648

2013

Link zum Volltext

Verfügbarkeit prüfen

Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation

Transplantation, 2005-09, Vol.80 (5), p.573

2005

Link zum Volltext

Verfügbarkeit prüfen

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S197-S197

2015

Link zum Volltext

Verfügbarkeit prüfen

A non‐fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-05, Vol.121 (5), p.456-459

2013

Link zum Volltext

Verfügbarkeit prüfen

Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma

European journal of haematology, 2012-08, Vol.89 (2), p.151-159

2012

Link zum Volltext

Verfügbarkeit prüfen

Close Monitoring of Cyclosporine A Concentration as a Means of Preventing Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Recipients

Biology of blood and marrow transplantation, 2014-02, Vol.20 (2), p.S277-S277

2014

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

European journal of haematology, 2001-02, Vol.66 (2), p.73-82

Vindelov, Lars

2001

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

European journal of haematology, 2001-02, Vol.66 (2), p.73-82

Vindeløv, Lars

2001

Link zum Volltext

Verfügbarkeit prüfen

605Clinically Applied Variation in Replication Kinetics During Episodes of Post-Transplant Cytomegalovirus (CMV) Infections

Open forum infectious diseases, 2014-12, Vol.1 (suppl_1), p.S27-S27

2014

Link zum Volltext

Verfügbarkeit prüfen

602Elevation in Liver Transaminase (ALT-flares) in Transplant (TX) Recipients: Risk factors and Consequences

Open forum infectious diseases, 2014-12, Vol.1 (suppl_1), p.S26-S26

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(59)
Science & Technology
(49)
Life Sciences & Biomedicine
(46)
Biological And Medical Sciences
(30)
Medical Sciences
(29)
Male
(27)
Female
(26)
Hematology
(23)
Middle Aged
(23)
Animals
(22)
Flow Cytometry
(21)
Adult
(18)
Mice
(18)
Aged
(15)
Transplantation, Homologous
(15)
Antineoplastic Agents
(14)
Pharmacology. Drug Treatments
(14)
Immunology
(13)
Oncology
(13)
Carcinoma, Small Cell - Drug Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2

Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.(Research Article)

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Haematopoietic stem cell transplantation with non‐myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

MHC Class II Tetramers Made from Isolated Recombinant [alpha] and [beta] Chains Refolded with Affinity-Tagged Peptides.(Research Article)

Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease

A non‐fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient

Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma

Close Monitoring of Cyclosporine A Concentration as a Means of Preventing Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Recipients

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

605Clinically Applied Variation in Replication Kinetics During Episodes of Post-Transplant Cytomegalovirus (CMV) Infections

602Elevation in Liver Transaminase (ALT-flares) in Transplant (TX) Recipients: Risk factors and Consequences

Suchergebnisse filtern